Cargando…
Poxvirus tropism
Despite the success of the WHO-led smallpox eradication programme a quarter of a century ago, there remains considerable fear that variola virus, or other related pathogenic poxviruses such as monkeypox, could re-emerge and spread disease in the human population. Even today, we are still mostly igno...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382915/ https://www.ncbi.nlm.nih.gov/pubmed/15738948 http://dx.doi.org/10.1038/nrmicro1099 |
_version_ | 1782364645502222336 |
---|---|
author | McFadden, Grant |
author_facet | McFadden, Grant |
author_sort | McFadden, Grant |
collection | PubMed |
description | Despite the success of the WHO-led smallpox eradication programme a quarter of a century ago, there remains considerable fear that variola virus, or other related pathogenic poxviruses such as monkeypox, could re-emerge and spread disease in the human population. Even today, we are still mostly ignorant about why most poxvirus infections of vertebrate hosts show strict species specificity, or how zoonotic poxvirus infections occur when poxviruses occasionally leap into novel host species. Poxvirus tropism at the cellular level seems to be regulated by intracellular events downstream of virus binding and entry, rather than at the level of specific host receptors as is the case for many other viruses. This review summarizes our current understanding of poxvirus tropism and host range, and discusses the prospects of exploiting host-restricted poxvirus vectors for vaccines, gene therapy or tissue-targeted oncolytic viral therapies for the treatment of human cancers. |
format | Online Article Text |
id | pubmed-4382915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-43829152015-04-02 Poxvirus tropism McFadden, Grant Nat Rev Microbiol Article Despite the success of the WHO-led smallpox eradication programme a quarter of a century ago, there remains considerable fear that variola virus, or other related pathogenic poxviruses such as monkeypox, could re-emerge and spread disease in the human population. Even today, we are still mostly ignorant about why most poxvirus infections of vertebrate hosts show strict species specificity, or how zoonotic poxvirus infections occur when poxviruses occasionally leap into novel host species. Poxvirus tropism at the cellular level seems to be regulated by intracellular events downstream of virus binding and entry, rather than at the level of specific host receptors as is the case for many other viruses. This review summarizes our current understanding of poxvirus tropism and host range, and discusses the prospects of exploiting host-restricted poxvirus vectors for vaccines, gene therapy or tissue-targeted oncolytic viral therapies for the treatment of human cancers. Nature Publishing Group UK 2005 /pmc/articles/PMC4382915/ /pubmed/15738948 http://dx.doi.org/10.1038/nrmicro1099 Text en © Nature Publishing Group 2005 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article McFadden, Grant Poxvirus tropism |
title | Poxvirus tropism |
title_full | Poxvirus tropism |
title_fullStr | Poxvirus tropism |
title_full_unstemmed | Poxvirus tropism |
title_short | Poxvirus tropism |
title_sort | poxvirus tropism |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382915/ https://www.ncbi.nlm.nih.gov/pubmed/15738948 http://dx.doi.org/10.1038/nrmicro1099 |
work_keys_str_mv | AT mcfaddengrant poxvirustropism |